scispace - formally typeset
J

James A. Thomson

Researcher at Morgridge Institute for Research

Publications -  407
Citations -  101214

James A. Thomson is an academic researcher from Morgridge Institute for Research. The author has contributed to research in topics: Embryonic stem cell & Stem cell. The author has an hindex of 104, co-authored 387 publications receiving 93683 citations. Previous affiliations of James A. Thomson include University of California, Berkeley & University of Illinois at Chicago.

Papers
More filters
Journal ArticleDOI

Embryonic Stem Cell Lines Derived from Human Blastocysts

TL;DR: Human blastocyst-derived, pluripotent cell lines are described that have normal karyotypes, express high levels of telomerase activity, and express cell surface markers that characterize primate embryonic stem cells but do not characterize other early lineages.
Journal ArticleDOI

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

TL;DR: This article showed that OCT4, SOX2, NANOG, and LIN28 factors are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells.
Journal ArticleDOI

Integrative analysis of 111 reference human epigenomes

Anshul Kundaje, +123 more
- 19 Feb 2015 - 
TL;DR: It is shown that disease- and trait-associated genetic variants are enriched in tissue-specific epigenomic marks, revealing biologically relevant cell types for diverse human traits, and providing a resource for interpreting the molecular basis of human disease.
Journal ArticleDOI

Human DNA methylomes at base resolution show widespread epigenomic differences

TL;DR: The first genome-wide, single-base-resolution maps of methylated cytosines in a mammalian genome, from both human embryonic stem cells and fetal fibroblasts, along with comparative analysis of messenger RNA and small RNA components of the transcriptome, several histone modifications, and sites of DNA-protein interaction for several key regulatory factors were presented in this article.
Journal ArticleDOI

Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

TL;DR: Results demonstrate that reprograming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.